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Abstract
The developmental potency of mouse embryonic stem (ES) cells, which is the ability to contribute 
to a whole embryo is known to deteriorate during long-term cell culture. Previously we have 
shown that ES cells oscillate between Zscan4- and Zscan4+ states, and the transient activation of 
Zscan4 is required for the maintenance of telomeres and genome stability of ES cells. Here we 
show that increasing the frequency of Zscan4 activation in mouse ES cells restores and maintains 
their developmental potency in long-term cell culture. Injection of a single ES cell with such 
increased potency into a tetraploid blastocyst gives rise to an entire embryo with a higher success 
rate. These results not only provide a means to rejuvenate ES cells by manipulating Zscan4 
expression, but also indicate the active roles of Zscan4 in the long-term maintenance of ES cell 
potency.
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Introduction
Mouse embryonic stem (ES) cells are prototypical pluripotent cells, which are derived from 
the inner cell mass (ICM) of blastocysts1,2. The most striking evidence of their pluripotency 
or high developmental potency (i.e., ability to contribute to many tissues in chimeric mice) 
has been demonstrated by injecting 10-15 ES cells into tetraploid (4N) blastocysts, which 
produces healthy pups entirely from ES cells3. It has been shown that even a single ES cell 
can form an entire healthy pup, though the success rate was extremely low (0.5%)4. 
Although ES cells have the capacity to maintain their high potency for many cell passages5, 
it is also widely recognized that even ES cells, in long-term culture, gradually lose their 
potency. It is thus of considerable interest if there is any intervention that can enhance or 
prolong the high potency of ES cells.
Recently, it has been shown that Zscan4 (Zinc finger and scan domain-containing protein 4), 
which is expressed specifically in 2-cell stage embryos 6 and ES cells6-9, is required for the 
maintenance of genome stability and a normal karyotype in ES cells7. Although only a small 
fraction (1~5%) of undifferentiated ES cells express Zscan4 at a given time6,8, essentially all 
of the ES cells in culture undergo the transient Zscan4+ state within 9 passages7. 
Undifferentiated ES cells thus oscillate between the Zscan4- state and the Zscan4+ state, 
during which dramatic events, including telomere extension, occur7. We and others have 
also shown that Zscan4 can enhance the efficiency and quality of iPSC formation10,11. 
Unlike other iPSC factors, Zscan4 is required only for the initial few days during iPSC 
formation, suggesting Zscan4's involvement in epigenetic reprogramming10. Given the 
unusual expression pattern and functions of Zscan4, we hypothesized that more frequent 
activation of Zscan4 further improves the quality of ES cells, including their developmental 
potency, in long-term cell culture.
Here we test the notion and demonstrate that ES cells can indeed acquire and maintain 
higher potency in long-term culture by more frequent activation of Zscan4 than in a normal 
ES cell condition. We also find that ES cells in the Zscan4+ state show lower potency than 
ES cells in Zscan4- state. These data indicate that ES cells can be rejuvenated by going 
through the transient Zscan4+ state, which loses the potency temporarily.
Results
Zscan4-ERT2 increases the frequency of endogenous Zscan4+ cells
Previously we have shown that constitutive expression of Zscan4 slows down or arrests the 
proliferation of both ES cells and mouse embryo fibroblast (MEF) cells10. We therefore 
used a plasmid construct pCAG-Zscan4-ERT2, in which a strong ubiquitous promoter 
CAG12 drives the expression of an open reading frame (ORF) of Zscan4c fused with a 
Tamoxifen (Tmx)-controlable ERT2 domain13 (Fig. 1a). When we transfected the pCAG-
Zscan4-ERT2 plasmid into MC1-ZE3 cells14 (129S6/SvEvTac strain) carrying an Emerald 
(GFP variant) reporter under the Zscan4 promoter7, we were surprised to find that the 
constitutive expression of Zscan4-ERT2 in ES cells increased the fraction of Em+ cells even 
in the Tmx- condition (Fig. 1b). Adding Tmx to the culture media further increased the 
fraction of Em+ cells, but also made the ES cells (both Em+ and Em-cells) flatter, resulting 
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in the flattening of ES cell colonies – a deviation from the typical pluripotent ES colony 
morphology (Fig. 1b). The results were further confirmed by quantitative assays for five 
independent clones: the constitutive expression of Zscan4-ERTs even in the absence of Tmx 
caused a 3-fold increase of Em+ cells by flow cytometry analysis (Fig. 1c) and a 5-fold 
increase by qRT-PCR analysis (Fig. 1d); and the addition of Tmx to the medium caused a 
further 2-fold and 1.2-fold increase, respectively (Fig. 1c, d).
To further investigate this unexpected result, we transfected the pCAG-Zscan4-ERT2 
plasmid into V6.5 ES cells derived from an F1 hybrid strain (C57BL/6 × 129/Sv), which has 
been extensively used for testing developmental potency4,15, and isolated multiple cell 
clones named V6.5 ZERT210. Based on qRT-PCR analysis of Zscan4 ORF, we selected 
clone #18 for the highest Zscan4 expression levels, clones #7 and #10 for the second and 
third highest Zscan4 levels, and clone #2 with a background Zscan4 level10. Based on 
genotyping by PCR, clone #2 did not have any copies of the pCAG-Zscan4-ERT2 plasmid, 
and was thus used as a control (V6.5 #2). To check if the frequency of Zscan4+ cells is 
increased even in the Tmx- condition, we carried out whole-mount in situ hybridization 
using a full-length Zscan4c probe to detect both endogenous and exogenous copies of 
Zscan4 as well as a 3’-UTR Zscan4c probe to detect only endogenous Zscan4. The results 
showed ~3-fold increase of the number of Zscan4+ cells in V6.5 ZERT2 ES cell clones (#10 
and #18) in the absence of Tmx compared to the usual level of Zscan4+ cells in the control 
cells (V6.5 and V6.5 #2) (Fig. 1e, Supplementary Fig. S1). Similarly, the number of V6.5 
ZERT2#18 cells expressing the Zscan4 protein was ~3-fold greater than the control V6.5 
cells (Supplementary Fig. S2a, b, c). The Zscan4 protein detected here by antibodies against 
Zscan4 was most likely endogenous Zscan4 proteins, because they constituted only ~3% of 
cells expressing the Zscan4-ERT2 fusion protein detected by antibodies against the ERT2 
domain (Supplementary Fig. S2d). The effect of Zscan4-ERT2 without its usual ligand Tmx 
may be partially explained by the presence of ~25% of Zscan4-ERT2 proteins leaked in 
nucleus in the absence of Tmx, although more Zscan4-ERT2 proteins (~56%) were 
translocated from cytoplasm to nucleus in the presence of Tmx, as expected (Supplementary 
Fig. S3). Taken together, use of constitutively expressing the Zscan4-ERT2 fusion protein 
without Tmx became an unexpected, but attractive strategy to enhance the naturally 
occurring Zscan4 effects by increasing the frequency of endogenous Zscan4 activation, 
resulting in more Zscan4+ cells in culture.
Zscan4-ERT2 enhances developmental potency of ES cells
To assess the effects of Zscan4-ERT2 on the developmental potency of ES cells, we injected 
various ES cells into mouse blastocysts, transferred them to uteri, and followed their 
development. The extent of ES cell potency was assessed by percent chimerism in the pups 
based on coat colors: high (>70% chimerism), moderate (40%-70%), low (<40%), and 
albino (0%) (Fig. 1f).
A V6.5 parental ES cell line at its early passage (passage 15; p15) showed 18% high, 29% 
moderate, and 41% low chimerism, which are within the standard range for F1 hybrid ES 
cell lines (Fig. 1g). It is known that the developmental potency of ES cells generally 
becomes lower after multiple passages and/or plasmid transfection/drug selection. As 
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expected, compared to a V6.5 parental ES cell line, the control V6.5 #2 ES cell line, which 
did not carry Zscan4-ERT2 but was generated after transfection and drug selection, showed 
a slightly lower overall potency, which was further reduced over multiple passages (p23, 
p26, and p30) (Fig. 1g). By contrast, V6.5 ZERT2 #18 ES cells showed much higher 
developmental potency than parental V6.5 and control V6.5 #2 ES cells: 73% high and 27% 
moderate chimerism at passage 19 (Fig. 1g). Even more surprising was that such a high level 
of potency was maintained for an extended period of time and passages: for example, even 
at passage 30, more than 40% of pups derived from V6.5 ZERT2 #18 ES cells showed high 
chimerism, whereas none of the pups derived from control V6.5 #2 ES cells showed high 
chimerism (Fig. 1g). We tested 5 other ES cell lines of different genetic backgrounds and 
found that potency-wise, none of these ES cell lines could even come close to V6.5 ZERT2 
#18 lines (Fig. 1g). Consistent with the flatter ES cell morphology mentioned above, the 
exposure to Tmx for 2 to 3 days lowered the potency of both V6.5 #2 and V6.5 ZERT2 #18 
ES cells relative to that in the Tmx-condition (Fig. 1g). The developmental potential of these 
ES cells were also assessed by the efficiency of germline transmission from the chimeric 
mice (Supplementary Table S1). Consistent with the developmental potency assessed by the 
chimerism, the V6.5 ZERT2#18 cell clone showed the highest overall efficiency for the 
germline transmission (22%) compared to other cell clones including the control V6.5 ES 
cells (7%).
Testing developmental potency by 4N complementation
It is widely recognized that the ultimate test for developmental potency is to see if ES cells 
alone injected into tetraploid (4N) blastocysts become an entire mouse16. We thus tested the 
potency of ES cells by injecting 10 to 15 cells into 4N blastocysts. Compared to early 
passage V6.5 ES cells reported previously, which have achieved 15 – 25 % pups alive at 
term15, V6.5 ES cells at passage 18-19 only produced 3% live embryos (Table 1). By 
contrast, V6.5 ZERT2 #18 ES cells showed a much higher success rate – 43% live embryos 
even at passage 19 (Table 1). Similarly, one of two other independent clones tested also 
showed a high success rate of producing live embryos (Table 1: V6.5 ZERT2#10). 
Interestingly, one common feature of these two clones was an upregulation of endogenous 
Zscan4 expression (Supplementary Fig. S1a).
To compare the high success rate of V6.5 ZERT2 #18 cells with those of the best ES cells 
possible, we freshly isolated ES cells from blastocysts with the same genetic background – 
F1 hybrid of C57BL/6J × 129S6/SvEvTac and cultured them in the best conditions currently 
available17 (Supplementary Table S2, Table S3, Fig. S4). Of the 13 ES lines established, one 
ES line, named “TA1”, showed the highest efficiency (60%) in producing live embryos, 
although its potency quickly decreased over multiple passages (Table 1). Overall, these 
results indicate that the developmental potency of V6.5 ZERT2 #18 ES cells even at a 
higher passage number was comparable to that of freshly isolated early passage ES cells.
To exclude the possibility that Zscan4-ERT2 affects only F1 hybrid ES cell lines, we 
generated MC2 ZERT2 ES cells by transfecting a pCAG-Zscan4-ERT2 plasmid into an 
MC2 ES cell line (C57BL/6J)14. Consistent with the reported low potency of C57BL/6J-
derived ES cells15,18, both MC2 ES cells at passage 17 and genetically modified MC2 ES 
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cells at passage 12-13 did not produce any live embryos (Table 1). By contrast, several 
independent MC2 ZERT2 cell lines successfully achieved the production of 4 - 15% live 
embryos, respectively, even after 17 passages (Table 1).
The unusually high developmental potency of V6.5 ZERT2 #18 cells prompted us to further 
examine the potency of single ES cells by the 4N complementation assay. It has been shown 
once that even a single ES cell can form a live pup, although the success rate is extremely 
low (1 mouse/192 injected blastocysts: 0.5%)4. As expected from the fact that we used the 
same cell line as the one used for the earlier study4, out of 71 single V6.5 ES cells (p18) 
injected, only one live embryo (1%) was obtained (Table 2). Similarly, of 77 single control 
V6.5 #2 ES cells, none of them produced live embryos (Table 2). By contrast, of 44 
tetraploid blastocysts received a single V6.5 ZERT2 #18 cell, 3 (7%) became complete 
embryos, 2 (5%) of which were alive at the time of dissection (Table 2). This unusually high 
level of potency for V6.5 ZERT2 #18 ES cells was indeed comparable to that of early 
passage TA1 ES cells with 4% live embryos (Table 2). Overall, these results indicate that 
the pCAG-Zscan4-ERT2 construct can be used as a tool to enhance the developmental 
potency of ES cells.
Forced expression of Zscan4 enhances developmental potency
Results obtained using Zscan4-ERT2 fusion protein thus far indicate that increasing the 
frequency of Zscan4+ cells can restore and maintain the developmental potency of ES cells. 
To test whether the Zscan4 gene itself can cause this effect, we established V6.5 ES cell 
lines carrying a Doxycycline (Dox)-inducible Zscan4c ORF linked to IRES-βgeo (Fig. 2a). 
After confirming the high Dox-inducibility of exogenous Zscan4 by qRT-PCR (Fig. 2b) and 
βgeo by LacZ-staining (Fig. 2c), we selected V6.5 tetZscan4 #10 (clone #10) for further 
studies. The qRT-PCR (Fig. 2b) and Emerald-reporter (Supplementary Fig. S5) assays 
showed that the Dox-induced exogenous Zscan4 expression also increased the number of 
endogenous Zscan4+ cells by ~3-fold. Dox-dependent upregulation of two Zscan4-inducible 
genes—Tmem92 and Stra8—was also confirmed (Fig. 2d). Although the antibodies against 
Zscan4 cannot distinguish between endogenous and exogenous Zscan4 proteins in this case, 
immunohistochemical analyses confirmed that 2-day Dox-treatment increased the number of 
cells expressing Zscan4 proteins (~50% of cells), which subsequently declined to the basal 
level by 1 day after Dox withdrawal (Fig. 2e; Supplementary Fig. S6). These results indicate 
that 2-day Dox treatment causes transient expression of Zscan4 in ~50% of V6.5 tetZscan4 
#10 cells.
Developmental potency was assayed by injecting 10-15 ES cells into individual 4N 
blastocysts and by examining the presence of live embryos at E13.5 (see above). Parental 
V6.5 ES cells (p12) as a control showed its standard potency (i.e., ~3% live embryos), 
which deteriorated to 0% by passage 24 and continued to be 0% at passage 30 (Fig. 2f). As 
expected, Dox-treatment for 2 days at passage 31 did not change the potency of V6.5 ES 
cells (Fig. 2f). By contrast, the initial exposure to Zscan4 by 6 day Dox/G418 treatment for 
clone isolation increased the potency from 3% (p12) to 11% (p18). By passage 21, the 
potency was slightly decreased, but another exposure to Zscan4 by 2 days of Dox treatment 
increased the potency further to 19% (p24). Subsequently, the potency declined again to 2% 
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(p27), but yet another exposure to Zscan4 by 2-day Dox treatment increased the potency to 
13% (p33). Similar trends continued for two more cycles of forced Zscan4 expression that 
we tested. Even at passage 48, the potency was 5%, which was more than passages 12-21 of 
the control V6.5 ES cells (Fig. 2f). As expected, we found that Dox-inducible Nanog19 did 
not increase the developmental potency of ES cells, suggesting that this is indeed a unique 
function of Zscan4 (Supplementary Fig. S7). Taken together, these results demonstrate that 
the forced and transient expression of Zscan4 itself could enhance and maintain the 
developmental potency of ES cells in long-term culture.
Zscan4+ ES cells do not show higher developmental potency
Expression of Zscan4 in the 2-cell embryos, but not in the ICM suggests that ES cells are a 
mixed population of ~5% of 2-cell like cells (i.e., Zscan4+ state) and ~95% of ICM-like cells 
(i.e., Zscan4-state)6. As it has been shown that by nuclear transplantation (cloning) the 2-cell 
nucleus has a higher developmental potential than the ICM nucleus20,21, it is tempting to 
speculate that the Zscan4+ state represents high-potential stem cells among the regular ES 
cell population. It is also conceivable that the enhancement of potency in ES cells after 
increasing the frequency of Zscan4 activation or after exposing ES cells to Zscan4 protein 
might simply be due to the increased presence of Zscan4+ cells in the culture.
To test this notion, we first sorted G4ZE#17 cells into Em+ and Em- cells by FACS and 
tested their developmental potency (Supplementary Table S4). Compared to non-sorted cells 
(62% chimerism), both Em- cells (2% chimerism) and Em+ cells (0% chimerism) showed 
very low chimerism. To test another cell clone and avoid possible cell damage caused by 
cell sorting, we separated the MC1ZE cells manually by mouth pipetting in the order of Em+ 
(under UV light), Em- (under UV light), and Em+/Em--mixed population (without UV light). 
To collect sufficient number of cells for blastocyst injections of 10-15 ES cells, Em+ cells 
included not only the highest Em+ expression, but also the medium-low Em+ expression. 
Based on the coat colors, we found that Em- ES cells were able to contribute to the tissues of 
chimeric mice at higher rate (75%) than Em+ ES cells (31%) (Table 3). Due to the order of 
cell picking, Em+/Em--mixed cells and Em- cells were exposed to the UV light longer than 
Em+ cells; therefore, it is unlikely that the reduced potency of Em+ cells was caused by the 
UV-induced cell damage. To test yet another cell clone, we generated and assessed the 
developmental potency of V6.5 ZE cells (clone #17) by transfecting a pZscan4-Emerald 
vector7 into V6.5 ES cells. We separated V6.5 ZE cells into Em+ or Em- cells manually by 
mouth pipetting, injected single ES cells into 2N blastocysts, and observed the subsequent 
embryo development. Based on the coat colors, we found that Em- ES cells were able to 
contribute to the tissues of chimeric mice at a relatively high rate (31%), whereas Em+ ES 
cells were not (Table 3). The results indicate that, contrary to our expectations, Zscan4+ cells 
are not associated with high developmental potency compared to Zscan4- cells. Consistent 
with this notion, we observed in at least one instance that too frequent activation of Zscan4, 
resulting in more Zscan4+ cells in culture, lowered the average potency of ES cells 
(Supplementary Fig. S8: TA1-ZERT2). Taken together, these data suggest that the Zscan4+ 
state is the process that restores potency, but the process itself (i.e., Zscan4+ state) has no or 
low potency.
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Characterization of ES cells with potency enhanced by Zscan4
In our earlier work, we have shown that Zscan4 extends telomeres and is responsible for the 
maintenance of normal karyotype of ES cells7. We therefore examined if the restoration of 
developmental potency of ES cells by transient activation of Zscan4 can be simply explained 
by better karyotype and longer telomeres. We indeed found that the lengths of telomeres 
were 2-fold longer in V6.5 ZERT2 #18 (p30) compared to control V6.5 #2 (Fig. 3a). This 
held true also for MC2 ES cells: MC2 ZERT2 #6 (p23) showed >2-fold longer than control 
MC2 ES cells (Fig. 3a). The standard low-resolution karyotype analysis showed that the 
karyotypes of V6.5 ZERT2#18 (p30) and V6.5 tetZscan4#10 (p30; Dox-treated for two days 
at p13, p21, and p28) were better than control V6.5#2 (p30) (Fig. 3b). With the high-
resolution G-banding karyotype analysis, the control V6.5#2 (p30) exhibited 72% tetraploid 
and 28% interstitial deletions and isochromosome 8, resulting in 0% normal karyotype (0 
normal karyotype out of 58 spreads analyzed), whereas V6.5 ZERT2#18 (p30) showed 
100% normal karyotype (18 normal karyotypes out of 18 spreads analyzed) (Supplementary 
Fig. S9, Table S5). The high-resolution G-banding analysis also revealed that V6.5 
tetZscan4#10 (p30; Dox-treated for two days at p13, p21, and p28) exhibited 0% tetraploid 
and 89% isochromosome 8, resulting in only 11% normal karyotype (2 normal karyotypes 
out of 18 spreads analyzed); however, additional 2-day Dox-treatment prior to the G-
banding analysis improved the karyotype, resulting in 63% normal karyotype (12 normal 
karyotypes out of 19 spreads analyzed) (Supplementary Fig. S9, Table S5). Taken together, 
telomere extension and karyotype maintenance account for at least a part of the enhanced 
potency caused by Zscan4.
To further understand the molecular mechanisms of Zscan4-mediated restoration of 
developmental potency, we compared the global gene expression profiles of these cells (Fig. 
3c; Supplementary Table S6, Table S7, Table S8). Zscan4 and other key Zscan4-related 
genes, such as Tcstv1/3 (Struwe, M. & Solter, D., GenBank/EMBL/DDBJ accession 
AF067057.1.)22, Eif1a, Tho4, Arginase II, GM428, AF067063, EG668777, 
RP23-149D11.5, BC061212, and EG627488, were more highly expressed in Zscan4+ cells 
than in Zscan4- cells (Fig. 3c; Supplementary Table S6). We also found that these genes are 
indeed expressed in Zscan4+ ES cells (Supplementary Fig. S10) and are expressed 
specifically in early preimplantation embryos (Supplementary Fig. S11). Consistent with the 
more frequent presence of Zscan4+ cells in V6.5 ZERT2 #18 ES cells, these genes were 
slightly upregulated in V6.5 ZERT2 #18 ES cells in the Tmx- condition (Fig. 3c, 
Supplementary Table S7). However, more dramatic upregulation was observed for genes in 
the well-known imprinted cluster: Rian (192-fold), Mirg (92-fold), and Meg3 (45-fold). 
Previously these genes were implicated as markers for ES cells with higher developmental 
potency 23,24. These results suggest that transient activation of Zscan4 made dramatic 
epigenetic changes to the ES cell genome, which persisted for a long time even without 
Zscan4 expression. However, it remains to be clarified whether these imprinted genes play a 
role in the function of Zscan4, as their strong upregulation were not observed in Zscan4+ ES 
cells and V6.5 tetZscan4 ES cells.
Given the beneficial effects of Zscan4 on ES cells, it is of particular interest to find if any of 
the cell culture conditions that are known to enhance the pluripotency of ES cells can 
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replace exogenous Zscan4. As a first step to address this issue, we tested the Knockout 
Serum Replacement (KSR)-supplemented medium, which is widely used for the efficient 
derivation and maintenance of ES cells 25, and the defined medium supplemented with the 
two inhibitors (2i) of the mitogen-activated protein kinase (ERK1/2) cascade and of 
glycogen synthase kinase 3, which is known to provide an optimal culture environment for 
mouse ES cells 26. We found that the responses to the KSR or 2i condition were slightly 
different between V6.5 (C57BL/6 × 129/Sv) and MC1 (129S6/SvEvTac) ES cells 
(Supplementary Fig. S12). In V6.5 ES cells, the 2i condition did not increase the number of 
Em+ cells in 2 days, but increased by ~3-fold in 5 days; in MC1 ES cells, the 2i condition 
increased the number of Em+ cells by ~2-fold in 2 days, but reduced to the original level in 5 
days. The KSR medium showed similar trends with slightly stronger responses than the 2i 
condition. The combination of the KSR and 2i condition showed only a modest additional 
increase. We also found that the KSR medium indeed increased the expression levels of 
Zscan4-related genes by day 5, but the 2i condition did not change the expression levels of 
these genes. Interestingly, the expression of so-called pluripotency genes (Rian and Gtl2) 
was not induced by neither the KSR nor 2i condition, whereas these genes were highly 
induced in V6.5ZERT2#18 cells based on our microarray data (Supplementary Table S7). 
Based on these results, the KSR medium seems to be a possible candidate to replace the 
exogenous Zscan4; however, relatively fast decline of the developmental potency of the 
aforementioned TA1 ES cells, which were indeed derived and maintained in the KSR 
medium all the time (Table 1; Supplementary Fig. S8), indicates that the exogenous Zscan4 
cannot be substituted by simply the KSR medium.
Discussion
It is known that ES cells oscillate between Zscan4- and Zscan4+ states7, leading to the 
presence of 1-5% Zscan4+ cells in an ES cell culture at a given time6-8. Here we have shown 
that the constitutive presence of Zscan4-ERT2, without its usual activator Tmx, can increase 
the frequency of ES cells in the Zscan4+ state, resulting in an increase of the developmental 
potency of ES cells. We have also shown that similar effects can be obtained by the periodic 
and transient overexpression of Zscan4 in a Dox-inducible system. The enhanced potency of 
ES cells by more frequent activation of Zscan4 than usual indicates that the interval of 
transient Zscan4 activation in the standard ES cell culture may be longer than the optimal 
interval (Fig. 3d). This suggests that ES cells steadily lose their developmental potency, 
which can be rapidly restored by the transient activation of Zscan4, although the frequency 
is less than optimal (Fig 3d). ES cells cultured in the accelerated Zscan4 activation cycle 
show improved chimerism and potency, which are demonstrated by high contribution to 
chimeric mice and efficient production of a whole mouse from a single ES cell. These ES 
cells also show longer telomeres, better karyotypes, and upregulation of imprinted genes 
previously implicated for higher developmental potency of ES cells. Overall, the 
introduction of Zscan4-ERT2 provides an effective means to maintain or increase 
(“rejuvenate”) the developmental potency of pluripotent stem cells in long-term cell culture.
Interestingly, our results show that the enhanced potency of ES cells with more frequent 
Zscan4 activation is not merely due to the presence of more Zscan4+ cells in culture: 
Zscan4+ cells showed no or lower potency than Zscan4- cells in the standard potency assay, 
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i.e., injecting into blastocysts. The results indicate that the potency of ES cells can be 
enhanced when ES cells experience a transient Zscan4+ state, which is in the middle of 
undergoing dramatic changes in their epigenetic status, and thus, is not potent. This seems to 
be consistent with our earlier findings: (i) Drastic changes, including rapid telomere 
extension by telomere sister chromatid exchange7 are occurring in ES cells in the Zscan4+ 
state; (ii) Forced and constitutive expression of Zscan4 in ES cells and mouse embryo 
fibroblast (MEF) cells slows down or arrests their proliferation10; (iii) The forced expression 
of Zscan4 for the initial few days enhances the efficiency of induced pluripotent stem cell 
(iPSC) formation10. Recently it has been reported that a rare population of ES cells that 
express endogenous retroviruses and 2-cell embryo genes possesses expanded fate potential 
with the ability to contribute to both embryonic and extraembryoic tissues 27. It appears that 
these rare cells are essentially the same as Zscan4+ cells, which also express Tcstv1/3 and 
other preimplantation genes highly and show a similar oscillatory appearance7. However, it 
remains to be clarified why two seemingly identical rare cell populations differ in their 
developmental potency.
METHODS
ES cell culture
MC1 ES cells 14 derived from 129S6/SvEvTac and MC2 ES cells14 derived from C57BL/6J 
were purchased from the Transgenic Core Laboratory of Johns Hopkins University School 
of Medicine, Baltimore, MD, USA. V6.5 ES cells15 derived from an F1 hybrid strain 
(C57BL/6 × 129/Sv) were purchased from Thermo Scientific Open Biosystem. All ES cell 
lines, except for TA1 ES cell line (see below), were cultured at 37 °C in 5% CO2 in the 
complete ES medium as previously described7: DMEM (Gibco), 15% FBS (Atlanta 
Biologicals), 1000 U/ml leukemia inhibitory factor (LIF) (ESGRO, Chemicon), 1 mM 
sodium pyruvate, 0.1 mM non-essential amino acids (NEAA), 2 mM GlutaMAX, 0.1 mM 
beta-mercaptoethanol, and penicillin/streptomycin (50 U/50 μg/ml). For all cell lines, 
medium was changed daily and cells were passaged every 2 to 3 days routinely.
Derivation of TA1 ES cell line
C57BL/6J females (The Jackson Laboratory) and 129S6/SvEvTac males (Taconic) were 
naturally mated to collect 2-cell embryos, which were then cultured in the KSOM medium 
for 3 days at 37°C in 5% CO2. Resulting blastocysts were transferred onto Mouse Embryo 
Fibroblast (MEF) feeder cells treated with Mitomycin C (Sigma) and cultured for 7 days in 
the complete ES medium after replacing 15% FBS with 15% KSR (Invitrogen) and adding 
50 nM PD98059 (MEK1 inhibitor). After picking ICM clumps and dissociating them by 
Accutase (Millipore), they were seeded onto fresh feeder cells and cultured in the same 
conditions for additional 7 days. Subsequently, TA1 ES cells were cultured in the same 
KSR-containing medium without MEK1 inhibitor. Newly derived ES cell lines were directly 
tested for their developmental potency by 4N-complementation (see below).
pCAG-Zscan4-ERT2 vector construction
Genes collectively called Zscan4 consist of 6 paralogous genes and 3 pseudogenes clustered 
on a ~850 kb region of chromosome 7 6. Among six paralogs named Zscan4a to Zscan4f, 
Amano et al. Page 9
Nat Commun. Author manuscript; available in PMC 2013 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
the open reading frames (ORFs) of Zscan4c, Zscan4d, and Zscan4f are very similar to each 
other and encode a SCAN domain and four zinc finger domains6. To construct a pCAG-
Zscan4-ERT2 plasmid, an entire ORF (506 a.a.) of mouse Zscan4c gene6 was fused with 
ERT213 (314 a.a.) and cloned into XhoI/NotI sites of pPyCAG-BstXI-IP (a gift from Dr. 
Hitoshi Niwa). The resultant plasmid vector expresses Zscan4c-ERT2 fusion protein-IRES-
Puromycin-resistant protein under a strong CAG promoter12.
Generation of ZE (Emerald reporter) and ZERT2 ES cell clones
ES cells were grown in 6-well plates. For ZE ES cell clones, 5×105 ES cells in suspension 
were transfected with 1 μg of a linearized pZscan4-Emerald vector7 using Effectene 
(Qiagen) according to manufacturer's protocol, into various cell lines - MC1, G4 (129S6/
SvEvTac × C57BL/6Ncr), TA1, and V6.5, and plated in 100 mm dishes. After selecting with 
5 μg/ml blasticidin for 8 days, resulting ES cell colonies were picked, expanded, and frozen 
for further analysis. For ZERT2 ES cell clones, 5×105 ES cells in suspension were 
cotransfected with 0.5 μg of a linearized pCAG-Zscan4-ERT2 vector and 0.5 μg of PL452 
(PGK promoter-Neo) 28 using Effectene, and plated in 100 mm dishes. After selecting with 
G418 for 8 days, resulting ES cell colonies were picked, expanded, and frozen for further 
analysis.
Generation of tet-Zscan4c ES cell clones
A PB-TET-Zscan4c-IRES-βgeo vector was constructed as previously described10. In brief, 
an ORF of Zscan4c was PCR-amplified from a pCAG-Zscan4-ERT2 vector by using a high-
fidelity DNA polymerase (Pfx50 or Platinum Pfx from Invitrogen) and attB1/2 primers and 
cloned into a pDONR221 vector (Invitrogen). Subsequently, the DNA fragment was inserted 
into a PB-TET-IRES-βgeo destination vector thorough the Gateway System (Invitrogen). 
Using Effecten , V6.5 ES cells were transfected with 0.7 μg of each plasmid: pCyL4329 
(Sanger institute), PB-CAG-rtTA, and PB-TET-Zscan4c. After 24 h, cells were fed with the 
complete ES medium with Doxycycline (Dox: 1.5 μg/ml) and G418 (400 μg/ml) for 6 days. 
Colonies were picked after 7 days post-Dox-induction and propagated as tet-Zscan4c ES 
cells in the complete ES medium.
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
RNA was isolated from cells by TRIzol (Invitrogen) in biological triplicate. 1 μg of total 
RNA was reverse transcribed by SuperScript III (Invitrogen) following the manufacturer's 
protocol. 100 ng of oligo dT primers (Promega) was used per reaction. For qPCR, SYBR 
green master mix (Applied Biosystems) was used following the manufacturer's protocol. 96-
well optical plates with a 25 μl total reaction volume were used, 10 ng of cDNA was used 
per well. Plates were run on 7300 or 7500 system (Applied Biosystems). Fold induction was 
calculated by the ΔΔCt method 30 using H2A as normalizer. A list of qPCR primer 
sequences can be found in Supplemental Table S9.
RNA isolation and qPCR analysis in preimplantation embryos
Four to six week-old B6D2F1 female mice were superovulated with 5 I.U. of PMSG 
(Sigma) and 5 I.U. of hCG (Sigma). Eggs or embryos for qRT-PCR experiments were 
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collected after 20, 23, 30, 43, 55, 66, 80 and 102 hours post hCG injection for MII, 1-cell, 
early and late-2 cell, 4-cell, 8-cell, morula and blastocyst embryos, respectively. Three sets 
of 10 synchronized eggs or embryos were stored in liquid nitrogen and mechanically 
ruptured by a freeze/thaw step for the cDNA preparation template. Oligo-dT primers and 
SuperScript III Reverse Transcriptase (Invitrogen) were used according to the 
manufacturer's instruction. Analysis was performed on the ABI 7300 Fast Real Time PCR 
system (Applied Biosystems). A list of qPCR primer sequences can be found in 
Supplemental Table S9. Data was normalized by Chuk 31 with the ΔΔCt method 30.
RNA in situ hybridization
Whole mount in situ hybridization was done as previously described8. Briefly, ES cells in 
triplicates, grown for 3 days, were fixed in 4% PFA at 4°C overnight. After digestion with 
proteinase K, cells were hybridized with 1 μg/ml digoxigenin-labeled riboprobe at 62°C 
overnight. Cells were then washed, blocked, incubated with alkaline phosphatase-conjugated 
anti-digoxigenin antibody, and incubated with NBT/BCIP detection buffer for 30 min or 
overnight.
Microarray analysis
DNA microarray analyses were carried out as described 32. Briefly, universal Mouse 
Reference RNA (Stratagene) were labeled with Cy5-dye, mixed with Cy3-labeld samples, 
and used for hybridization on the NIA Mouse 44K Microarray v2.2 33 (manufactured by 
Agilent Technologies #014117). The intensity of each gene feature was extracted from 
scanned microarray images using Feature Extraction 9.5.1.1 software (Agilent 
Technologies). Microarray data analyses were carried out by using an application developed 
in-house to perform ANOVA and other analyses (NIA Array Analysis software; http://
lgsun.grc.nia.nih.gov/ANOVA/) 34. All the DNA microarray data have been deposited to the 
NCBI Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are 
accessible through GEO Series accession number (GSE26278) and the NIA Array Analysis 
software website (http://lgsun.grc.nia.nih.gov/ANOVA/)34.
ES cell injection into 2N or tetraploid (4N) blastocysts
CD1 females (Charles River, 8-12 week old) were used for superovulation by PMSG 
(Sigma) followed 48hrs later by hCG (Sigma) administration. After hCG administration, 
females were mated with males of the same strain and 2-cell embryos were collected by 
flushing oviducts. Recovered embryos were cultured in KSOM (Millipore) medium for 3 
days at 37 °C in 5% CO2. Collected 2-cell embryos were directly transferred into 0.3M 
Mannitol solution and aligned automatically by alternate current (AC) pulse in an 
electrofusion chamber. Then two direct current (DC) pulses with 140V/mm were applied for 
40 μs using LF101 Electro Cell Fusion Generator. Fused embryos (4N) that have one 
blastomere were collected at 60 min cultivation and then continued to culture in KSOM 
medium till they reached the blastocyst stage. A single ES cell or 10-15 ES cells were 
injected into 2N or 4N blastocysts to assess their developmental potency and then 
transferred to E2.5 recipient females. To study the effects of Tmx on ES cells, ES cells were 
cultured in the presence of 200 nM Tmx for 2 – 3 days before injection.
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Telomere measurement by quantitative real-time PCR
Genomic DNA was extracted from 106 cells in biological triplicates and quantified by 
Nanodrop. Average telomere length ratio was measured from total genomic DNAs using a 
real-time PCR assay, as previously described7, 35. PCR reactions were performed on the 
7500 real-time PCR System (Applied Biosystems) using telomeric primers, control single-
copy gene Rplp0, and PCR settings as previously described 35. Fold induction was 
calculated by the ΔΔCt method30.
Immunostaining of Zscan4
ES cells were cultured on the12 well-plate, washed by PBS, fixed for 10 min with 4% PFA, 
washed by PBS twice, and then treated with 0.25% NP-40 for the permeabilization. Saponin 
block solution (1%BSA, 10%FBS, 0.2% Saponin in PBS) was applied for the blocking for 
30 min and then plates were incubated overnight at 4°C with rabbit anti-Zscan4 antibodies7.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Constitutive expression of a Zscan4c-ERT2 fusion protein increases developmental 
potency
a, The structure of a Zscan4c-ERT2 fusion protein. Zscan4c contains one SCAN domain and 
four C2H2 zinc finger domains. b, Fluorescence microscopy of MC1-ZE3 cells, in which a 
Zscan4 promoter drives the expression of Emerald marker (left), MC1-ZE3-ZERT2 clone 
#15 cells, in which the Zscan4c-ERT2 fusion protein is constitutively expressed, cultured in 
the absence of Tmx (middle), MC1-ZE3-ZERT2 clone #15 cells cultured in the presence of 
Tmx for 3 days (right). Scale bar, 50 μm.
c, Flow-cytometry analysis of MC1-ZE3 ES cells (left, control) and MC1-ZE3-ZERT2 #15 
ES cells (right) in the absence or presence of 1 μM Tmx. Em fluorescence levels (average ± 
S.E.M.; n=6) are shown. Note 3-fold increase of Em+ cells by the constitutive expression of 
a Zscan4c-ERT2 fusion protein even without Tmx. d, Quantitative RT-PCR analysis of 
endogenous Zscan4 expression measured by using PCR primer pairs specific for 3’-UTR of 
Zscan4 in MC1-ZE3 ES cells (left, control) and MC1-ZE3-ZERT2 #15 ES cells (right) in 
the absence or presence of 1 μM Tmx. The fold-induction of endogenous Zscan4 expression 
levels (average ± S.E.M.; n=6) compared to that of control MC1-ZE3 is shown. Note the 6-
fold increase of endogenous Zscan4 at the RNA level by the constitutive expression of a 
Zscan4c-ERT2 fusion protein even without Tmx. e, V6.5 parental ES cells (passage number 
14), V6.5 ZERT2 #2 (p.20), V6.5 ZERT2 #18 (p.22) ES cell colonies after whole-mount 
RNA in situ hybridization of a Zscan4 full-length probe, which detects both endogenous and 
exogenous Zscan4 RNAs: upper panel) or a Zscan4 3’-UTR probe, which detects only 
endogenous Zscan4 RNAs. Scale bar, 100 μm. f, Representative coat colors of chimeric 
mice generated by injecting various ES cells into blastocysts. Higher chimerism represents 
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higher contribution of injected ES cells to mice, indicating higher developmental potency of 
the ES cells. g, Percent distribution of chimerism levels among “n” number of mice born 
from various ES cell lines.
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Figure 2. Forced expression of Zscan4 enhances developmental potency of ES cells
a, Schematic presentation of experimental procedure. b, Expression levels of Zscan4 
(endogenous and ORF) in Dox+ and Dox- conditions in G418-selected clones. Error bars 
indicate S.E.M., n=3 c, Forced expression of βgeo in Dox+ and Dox- conditions. d, 
Induction of Stra8 and Tmem92 (Zscan4-downstream genes) in Dox+ condition. Error bars 
indicate S.E.M., n=3 e, Forced expression of Zscan4 protein detected by 
immunohistochemistry. Scale bar, 100 μm. f, Assessment of developmental potency of ES 
cells by 4N complementation assays.
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Figure 3. Molecular features of ES cells expressing Zscan4-ERT2 and a proposed mode of 
Zscan4 actions
a, Constitutive presence of Zscan4-ERT2 and forced expression of Zscan4 made telomeres 
longer than controls in both F1-hybrid (129/C57BL/6)-derived ES cells (V6.5) and 
C57BL/6-derived ES cells (MC2). Telomere lengths (average ± S.E.M.; n=3) are shown. b, 
Constitutive presence of Zscan4-ERT2 and forced expression of Zscan4 maintained better 
karyotype in long-term-culture of ES cells. c, Comparisons of global expression profiles 
between V6.5 ZERT2 #18 ES cells and V6.5 #2 control ES cells (left scatter plot) and 
between MC1 Em+ (Zscan4+) ES cells and Em- (Zscan4-) ES cells (right scatter plot). Red 
and green dots represent genes that show expression differences with statistical significance 
(False discovery rate < 0.05 and fold-change > 2). Venn diagram showing the overlap 
between genes that are more highly expressed in V6.5 ZERT2 #18 cells than V6.5 #2 cells 
and genes that are more highly expressed in Em+ (Zscan4+) cells than Em- (Zscan4-) cells 
Amano et al. Page 18
Nat Commun. Author manuscript; available in PMC 2013 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
(center). d, A proposed model. Upper panel: ES cells oscillate between Zscan4- and Zscan4+ 
states, resulting in the normal ES cells with only 1% - 5% of Zscan4+ cells. While in 
Zscan4- state, the potency of ES cells gradually decreases, which is restored to some extent 
by transient activation of Zscan4 (Zscan4+ state). However, the potency of ES cells still 
decreases during the long-term culture. Lower Panel: When the Zscan4 is more frequently 
activated by expressing an exogenous Zscan4, ES cells are rejuvenated more frequently, 
resulting in the longer maintenance of the high developmental potency.
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